{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:07:10Z","timestamp":1777694830777,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ygyno.2008.06.035","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T11:13:33Z","timestamp":1219922013000},"page":"249-254","source":"Crossref","is-referenced-by-count":60,"title":["A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I\u2013IV uterine carcinosarcoma"],"prefix":"10.1016","volume":"111","author":[{"given":"Vicky","family":"Makker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaled M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol. A.","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martee L","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.06.035_bib1","unstructured":"http:\/\/www.cancer.org\/docroot\/home\/index.asp, November 2006."},{"key":"10.1016\/j.ygyno.2008.06.035_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: a debated clinical challenge","volume":"65","author":"Gadducci","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2008.06.035_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2007.07.070","article-title":"A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide-mesna (CIM) as post-surgical therapy in stage I\u2013IV carcinosarcoma (CS) of the uterus","volume":"107","author":"Wolfson","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.06.035_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0360-3016(80)90334-X","article-title":"The role of radiation therapy in the management of uterine sarcomas","volume":"6","author":"Salazar","year":"1980","journal-title":"Int. J. Radiat. Oncol. Phys."},{"key":"10.1016\/j.ygyno.2008.06.035_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/gyno.1997.4827","article-title":"Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study","volume":"67","author":"Sartori","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.06.035_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<512::AID-CNCR13>3.0.CO;2-4","article-title":"Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients","volume":"82","author":"Iwasa","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.06.035_bib7","series-title":"Principles and practice of gynecologic oncology","first-page":"883","article-title":"Corpus: mesenchymal tumors","author":"Sutton","year":"2004"},{"key":"10.1016\/j.ygyno.2008.06.035_bib8","first-page":"661","article-title":"Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group study","volume":"71","author":"Slayton","year":"1987","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ygyno.2008.06.035_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygyno.2005.05.015","article-title":"Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"98","author":"Miller","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.06.035_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E","article-title":"A randomized study of Adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas","volume":"52","author":"Omura","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.06.035_bib11","first-page":"271","article-title":"Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group study","volume":"70","author":"Thigpen","year":"1986","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ygyno.2008.06.035_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9378(89)90507-3","article-title":"Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study","volume":"161","author":"Sutton","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.06.035_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygyno.2005.05.015","article-title":"A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"98","author":"Sutton","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.06.035_bib14","doi-asserted-by":"crossref","unstructured":"Homsley HD, Filiaci V, Markman M, et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group study. 2007;25:526\u201331.","DOI":"10.1200\/JCO.2006.06.4907"},{"key":"10.1016\/j.ygyno.2008.06.035_bib15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ygyno.2004.05.048","article-title":"Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus","volume":"94","author":"Toyoshima","year":"2004","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808004988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808004988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T17:08:55Z","timestamp":1557767335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808004988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0090825808004988"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.06.035","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}